1SB-LSD
1SB-LSD, or 1BS-LSD, also known as 1-TMSBz-LSD or as 1-(4-(trimethylsilyl)benzoyl)-LSD, is a psychedelic drug of the lysergamide family related to lysergic acid diethylamide (LSD).
≈ 1 min read
Names in other languages
No names in other languages are held for this entry yet.
Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.
1SB-LSD, or 1BS-LSD, also known as 1-TMSBz-LSD or as 1-(4-(trimethylsilyl)benzoyl)-LSD, is a psychedelic drug of the lysergamide family related to lysergic acid diethylamide (LSD). It is thought to be a prodrug of LSD. The drug was encountered online as a novel designer drug in September 2025.
1SB-LSD has been sold in the form of blotter, for instance containing 165 μg per tab. It is the derivative of 1Bz-LSD (SYN-L-018) in which there is a 4-trimethylsilyl group on the benzyl ring. 1SB-LSD was first described in the scientific literature by 2026.
It is not an explicitly controlled substance in the United States or in Canada.
See also
Substituted lysergamide
Text derived from https://en.wikipedia.org/w/index.php?oldid=1368191491 under CC BY-SA 4.0; modifications have been made.